Diversified Healthcare Trust – (NASDAQ:DHCNI) Short Interest Up 121.8% in December

Diversified Healthcare Trust – (NASDAQ:DHCNI) saw a significant growth in short interest in the month of December. As of December 15th, there was short interest totaling 8,628 shares, a growth of 121.8% from the November 30th total of 3,890 shares. Based on an average daily volume of 18,123 shares, the days-to-cover ratio is currently 0.5 days. Based on an average daily volume of 18,123 shares, the days-to-cover ratio is currently 0.5 days.

Diversified Healthcare Trust Trading Up 1.0%

Shares of DHCNI stock opened at $16.91 on Monday. The stock has a 50 day simple moving average of $16.99 and a 200 day simple moving average of $16.83. Diversified Healthcare Trust has a 1 year low of $12.79 and a 1 year high of $18.29.

Diversified Healthcare Trust Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Saturday, November 1st. Stockholders of record on Wednesday, October 15th were given a dividend of $0.3516 per share. This represents a $1.41 dividend on an annualized basis and a dividend yield of 8.3%. The ex-dividend date was Wednesday, October 15th.

Diversified Healthcare Trust (NASDAQ: DHCNI) is a publicly traded real estate investment trust (REIT) specializing in healthcare and life science properties. The company’s primary business activities include the acquisition, development, ownership and management of net‐leased medical office buildings, senior housing facilities and life science research and development assets. In addition to property investments, Diversified Healthcare Trust holds mortgage loans and preferred equity interests in the healthcare sector, offering diversified exposure to both real estate and structured financing arrangements.

The company’s portfolio spans a broad range of healthcare asset types, including medical office buildings leased to health systems and physician groups, senior living communities operated by leading care providers, and life science campuses serving biotechnology and pharmaceutical companies.